The persistent shortage of dermatologists in the United States affects access to care and patient outcomes.
T here is an ongoing shortage of dermatologists in the United States. 1 The number of practicing dermatologists in the country has not changed in 20 years despite the increasing incidence of skin cancer in an aging population. 1, 2 Challenges to accessing dermatological care still persist, even though there is greater reliance on midlevel clinicians and nondermatologist physicians performing skin-related procedures. 3, 4 Access is further exacerbated by uneven geographic distribution of dermatologists. 5 Little is known about the provision of dermatology services in areas with poor access to dermatologists. Poor dermatology access has implications for patients, as higher densities of dermatologists have been correlated with better patient outcomes, including more accurate diagnoses and improved melanoma survival. [6] [7] [8] In this study, we seek to characterize the effect of geographic variations in dermatologist density on the provision of dermatology procedures within Medicare.
Methods
Physician density and utilization were calculated from the 2013 Medicare Provider Utilization and Payment Data from the Centers for Medicaid and Medicare Services (CMS). 9 This publicly available database includes all billed charges to Medicare Part B fee-for-service plans by noninstitutional clinicians. Clinicians outside the 50 states and Washington, DC, were excluded. "Family practice," "internal medicine," and "general practice" physicians were aggregated under "primary care." Dermatology-related procedures were defined by the top 50 procedural codes accounting for more than 95% of the 29.1 million procedures billed by dermatologists. Evaluation and monitoring visits (billing codes starting with "99") were excluded because they were not specific to dermatology. Dermatopathology codes were excluded.
Historical population estimates for persons 65 years or older were obtained from the American Community Survey (data set DP05) published by the US Census Bureau.
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Dermatologist-to-population and utilization-to-population ratios were calculated per 3-digit zip code area (section codes). All analysis was performed using patients 65 years or older, reflecting the Medicare-eligible population. Reimbursement rates were obtained from the CMS physician fee schedule using the nonfacility national payment amount with no modifiers.
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Correlation between dermatology procedural spending and dermatologist density was calculated through linear regression modeling, which provided a quantitative measure for supply-sensitive variation in utilization. R (version 3.3.2) was used for data management and statistical analysis was performed in Stata/MP 14.1. This study was deemed exempt by the Partners Healthcare institutional review board.
Results

Geographic Variation in Dermatologist Distribution
A total of 10 391 practicing dermatologists accepted Medicare payments in 2013. Dermatologist density ranged from 5.3 per 100 000 persons 65 years or older in the first quintile to 54.8 per 100 000 persons 65 years or older in the fifth quintile. A total of 2.38 million residents 65 years or older lived in the 164 section codes with no dermatologists (Table) .
The top 50 billing codes accounted for 96.6% of total procedural volume billed by dermatologists (eTable in the Supplement). The most common codes were 17003, destruction of multiple premalignant growths (47%); 17000, destruction of single premalignant growth (14%); 11100, biopsy of single skin growth (9%); 17110, removal of multiple benign skin lesions (4%); and 11101, biopsy of second or subsequent skin growths (4%).
Physician Density and Variation in Dermatology Procedures
A total of 44 million dermatologic procedures were performed at a cost of $2.67 billion in 2013. Of these, dermatologists billed Medicare for 28 million procedures (64% of total) (Table) .
Mix of Dermatology Procedures by Clinician Type
Although practice patterns were qualitatively consistent across quintiles, utilization of specific dermatology procedures differed among clinician types. Destruction of premalignant lesions accounted for 66% of billed procedural volume for dermatologists, compared with just 9% among primary care physicians (PCPs). Primary care physicians and other specialists most commonly performed injections (89% and 74%, respectively). Nurse practitioners and physician assistants performed both destruction of premalignant lesions (48%) and injections (30%) (Figure) .
Discussion
Our study provides evidence for supply-sensitive variation in dermatology procedural utilization for the Medicare-eligible population, as higher dermatologist density is correlated with increased spending on dermatology procedures. Practice patterns also differed among clinician types, with dermatologists most commonly billing for destruction of premalignant lesions (66%) and skin biopsies (13%), PCPs primarily billing for injections (89%), and nurse practitioners and physician assistants performing both procedures (48% destruction of premalignant lesions, 30% injections). Supply-sensitive variation in care, termed Roemer's law, is a well-established concept in health care, and its essence is captured by Milton Roemer's observation that "a built hospital bed is a filled hospital bed." 12, 13 This differentiates health care from most other industries, in which supply and demand achieve market equilibrium. Such market dynamics fail in medicine for 2 reasons: (1) insured patients are priceinsensitive because they pay small out-of-pocket costs, and (2) demand is influenced by clinical decision-making of clinicians who are incentivized to increase volume within a fee-for-service model.
14,15
It may be that a high density of dermatologists and utilization of dermatologic procedures is necessary for optimal outcomes. Existing literature suggests that patients living in areas with high density of dermatologists have reduced melanoma mortality. [5] [6] [7] If mortality reduction is causally related to increased utilization of dermatology procedures, training more dermatologists and incentives to practice where there are fewer dermatologists may improve patient outcomes. However, training additional dermatologists without addressing maldistribution may promote inefficiency. Utilization may further rise in high-density areas, and increased competition could lead to market cannibalization between competing clinicians. Our data already suggest this, as average utilization on a per-dermatologist basis is lower in the fifth quintile vs the first quintile ($1.68 vs $2.99 per person ≥65 years, respectively). Other explanations must be entertained; dermatologists in higher-density quintiles may have nonclinical responsibilities (eg, physicians at academic centers) or cashbased practices (eg, cosmetics) that reduce their Medicarebillable volume.
Our data also reveal practice patterns of nondermatologists providing dermatologic care. Although several studies have noted that PCPs perform dermatologic procedures, our results suggest they may be imperfect substitutes for dermatologists. 8 Across all quintiles, PCPs primarily bill for injections rather than for skin biopsies or destructions of premalignant lesions, which limits their ability to diagnose and treat skin cancer.
Limitations
These findings must be interpreted in the context of our study design. The data set does not report on outcomes, nor can we access patient health records to determine whether rendered treatment follows practice guidelines. We cannot precisely quantify "demand" as defined by the number of patients requiring clinically indicated dermatological procedures. Thus, we cannot conclude whether supply begets demand, or whether there is globally high demand that is more adequately met in areas with more dermatologists. This study excluded evaluation and monitoring and dermatopathology codes, so results reflect only procedural dermatologic care. Skin cancer treatments through topical prescription medications are excluded. Finally, physicians practicing in the highest-density dermatology quintiles may serve patients commuting from underserved areas, but we cannot account for this in the data.
Conclusions
This study suggests that supply-sensitive variation in care exists in dermatology, for higher dermatologist density is correlated with increased procedural utilization. Further research is needed into how such variation affects patient outcomes and whether incentives can better redistribute dermatologists to meet clinical needs.
